Drug-induced nephrolithiasis: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System
This comprehensive pharmacovigilance study has revealed many drugs potentially associated with an increased risk of nephrolithiasis. Notably, vigilant surveillance for nephrolithiasis risk while using these drugs is crucial in clinical practice.
Authors
- Jiayu Liang
- Xinyuan Wei (ORCID: https://orcid.org/0000-0001-9337-333X)
- Yu Shen (ORCID: https://orcid.org/0000-0002-0167-458X)
- Yang Yang (ORCID: https://orcid.org/0000-0001-5171-6226)
- Zhenhua Liu (ORCID: https://orcid.org/0000-0003-1926-6020)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Jiujiang First People's Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1080/14740338.2024.2446415
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00